Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine.

UnitedHealth's valuation metrics indicate a potential buy-the-dip opportunity, with forward ratios mostly below their ...

The researchers looked at claims with a diagnosis of neuropathic pain in the Optum Claims database from May 1, 2018, to Sept. 30, 2023.

Scilex (SCLX) announced that Pain Medicine News published retrospective claims data on ZTlido vs. lidocaine 5% patch. Pain Medicine News, the ...

UnitedHealthcare Insurance Co. and subsidiary Optum Inc. must defend claims that they violated federal benefits law by ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

The suit comes exactly one year after 22-year-old Cole Schmidtknecht died from cardiac arrest after suffering a severe asthma attack.

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

UnitedHealth’s net income plummeted to its lowest level since 2019 amid hefty costs, including some from the Change ...

UnitedHealth Group reported $14.4 billion in 2024 profits as its UnitedHealthcare health insurance and Optum provider ...